• The Effect Of Antidiabetic Agent Glibenclamide And Meltformine On Lipids And Glycated Haemoglobin In Type 2 Diabetes Patient Attending Uith Ilorin

  • APPENDIX A -- [Total Page(s) 1]

    Page 1 of 1

    • APPENDIX I
      QUESTIONAIRE TO ACCESS THE ANTHROPOLOGIC INDICES OF PATIENTS WITH TYPE TWO DIABETES MELLITUS ON ANTIDIABETIC DRUGS (METFORMIN AND GLIBENCLAMIDE) ATTENDING UITH ILORIN.
      INTRODUCTION: I am a final year students of the Department of Medical Laboratory Science, School of Basic Medical Sciences, Kwara State University, Malete, Kwara State. This questionnaire is aimed at accessing the demographic indices of patients with type 2 Diabetes mellitus on metformin and diabinese in Ilorin metropolis, Kwara State. All information provided here will be treated with utmost confidentiality and be utilized for the purpose of this study.
      Please kindly help complete the questionnaire, your name is not compulsory. Tick appropriate boxes and thanks for your anticipation.
      Identification number
      INSTRUCTION: please tick in the appropriate box
      1 .Age .....................................................................Years
      2. Occupational status…………………………………………………………….
      3. State of Origin: ....................................................................................................
      4. Marital status: Single               Married
            If married, how many number of children…………………………………
      5. Level of formal Education:  None          Primary         Secondary             Tertiary
      6. Do you Smoke:    Yes          No
          If yes, name the cigarettes you smoke: ………………………………………………
      7. Do you drink Alcohol?  Yes            No   
      8. Height...........................cm
      9. Weight...........................kg
      10. Do you have Diabetes mellitus?   Yes                No
      11. Age when you are diagnosed of Diabetes mellitus................................years
      12. Any family history of diabetes? Yes                 No 
      13. If yes, what is the relationship between you and the family member ...............................
      14. How often do you test your blood sugar? ....................................
      15. Are you on antidiabetes drugs?     Yes            No  
      16 Are you currently taking any of these diabetes pills? METFORMINDIABINESE
      17. How long have you been taking the pills? ........................................
      18. Do you have any other medical challenge(s)?    Yes              No                                                                                                      
           If yes, does it include any of the following? Hypertension          ulcer            Heart disease                                                                                                                                                                
            Kidney disease    others
      19. How many times do you eat per day? 1            2           3           4           5
      20. State the combination of food you eat at a time………………………………….....
  • APPENDIX A -- [Total Page(s) 1]

    Page 1 of 1

    • ABSRACT - [ Total Page(s): 1 ]Abstract Is Coming Soon ... Continue reading---

         

      APPENDIX B - [ Total Page(s): 5 ]Step 2100µl of the supernatant was dispensed into the clean test tubes respectively.2ml of the cholesterol reagent was addedIt was incubated at room temperature for 10minsAbsorbance of sample against reagent blank was measured at 505nmGlycated HaemoglobinGlycated Haemoglobin is a form of haemoglobin that is measured primarily to identify the three-month average plasma glucose concentration. The test is limited to a three-month average.ProcedureReagentsBlank(µl)             samp ... Continue reading---

         

      CHAPTER ONE - [ Total Page(s): 2 ]The present study was designed to investigate and compare the effects of glibenclamide and metformin on prevalence of metabolic syndrome in type 2 diabetic patients.1.2    STATEMENT OF PROBLEMTo know if antidiabetic agents glibenclamide and meltformine has any effect on lipid and glycated haemoglobin in type 2 diabetes patients1.3     AIM OF STUDYTo evaluate the effect of antidiabetic agent glibenclamide and meltformine on lipids and glycated haemoglobin in type 2 diabetes patient attendi ... Continue reading---

         

      CHAPTER TWO - [ Total Page(s): 11 ]Triglycerides as major components of very low-density lipoprotein (VLDL) and chylomicrons, play an important role in metabolism as energy sources and transporters of dietary fat. They contain more than twice as much energy (approximately 9kcal/g or 38kj/g) as carbohydrates (approximately 4kcal/g or 17kj/g) (Brefere et al., 2014).2.5 Glycated hemoglobin (hemoglobin A1c, HbA1c, A1C, or Hb1c; sometimes also referred to as being Hb1c or HGBA1C) is a form of hemoglobin that is measured primarily to i ... Continue reading---

         

      CHAPTER THREE - [ Total Page(s): 1 ]CHAPTER THREE3.1    Material and Method3.2 Study AreaThe study was carried out at University of Ilorin Teaching Hospital, Ilorin, Kwara State. The hospital is located at the State capital of Ilorin, Kwara State Nigeria. It is a referral center to other public and private hospitals within and outside the state.3.3    SAMPLE SIZE DETERMINATIONThere was a random selection of ninety (90) subjects, 60 were type 2 Diabetes mellitus individual using either one or combine antidiabetic agent (glibe ... Continue reading---

         

      CHAPTER FOUR - [ Total Page(s): 4 ]Tables 4.6: Correlation of Duration in Diabetes and BMI with biochemical parameters (T. cholesterol, High Density Lipoprotein, Low Density Lipoprotein, triglycerides, glycated, and fasting blood sugar) in Diabetic patient using antidiabetic drugs (Metformin and Glianpride). ... Continue reading---

         

      CHAPTER FIVE - [ Total Page(s): 2 ]CHAPTER FIVE5.0 DISCUSSIONThe study shows discrepant results about the influence of metformin on lipid profile (10). Some studies, in agreement with ours, reported reduction only in TC levels (Grant, 1996; Ginsberg et al., 1999), while others reported reduction of TC and TG with an increase of HDL-C (Robinson et al., 1998; Yki-Jarvinen et al., 1999). Still other studies showed no changes in lipid profile (Groop et al., 1998; Rains et al., 1998). Another investigation showed an association of met ... Continue reading---

         

      REFRENCES - [ Total Page(s): 3 ]Rodger, W. (2012). Sulphonylureas and heart disease in diabetes management. Diabetes Spectrum. Pg. 12–27.Rosenbaum, M. and Leibel, R. L. (2014). Role of leptin in energy homeostasis in humans. Journal of Endocrinology. 223(1): 83-96.Rowley, D.E. and Bezold, D.C. (2012). Using new insulin strategies in the outpatient treatment of diabetes: clinical applications. Journal of American Medical Association. Pg. 289.Shaw, D., De Rosa, N. and Di Maro, G. (2010). Metformin improves glucose, lipid ... Continue reading---